New York Senate Bill S08949

New York 2025-2026 Regular Session

• Introduced: 1/20/26
• Refer: 1/20/26

Caption

Limits the reimbursement amount of certain overpayment claims and reviews where such overpayment was due to the provider's submission of records which were not in accordance with program requirements at the time but which were in accordance with current requirements as a result of changes to guidelines or regulations.

Impact

If enacted, S08949 would significantly alter the process of how overpayment claims are handled within the Medicaid program, particularly benefiting providers by limiting the financial repercussions of technical compliance failures. Providers would not face additional reviews or recoupments based on past discrepancies, provided there was no fraud involved. This could promote a more stable financial environment for healthcare providers by reducing the financial risks associated with changing requirements.

Summary

Bill S08949 seeks to amend New York's public health law by setting forth conditions regarding audits and reviews of medical assistance program funds conducted by the Medicaid inspector general. The bill specifically addresses scenarios where a provider submits records for reimbursement that do not adhere to program requirements at the time of the claim but comply with current requirements due to intervening changes in guidelines or regulations. The primary focus is on ensuring that recoupment for disallowed claims is limited to amounts that were actually reviewed by the inspector, avoiding extrapolation for broader overpayment assessments.

Contention

The bill may face contention primarily around its implications for accountability and financial management within the Medicaid system. Critics may argue that by limiting the auditor's ability to recoup funds based on extrapolated findings, the bill could inadvertently foster an environment where providers are less meticulous about adhering to current guidelines, knowing that their financial liabilities are capped. This potential risk to program integrity could spark debates on how to balance provider protections with rigorous oversight to prevent fraud and ensure responsible use of public funds.